The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 74, Issue 1, 2015, Pages e3-

  Van Steenbergen, H W ^a   Ajeganova, Sofia ^b   Forslind, K ^c,d   Svensson, B ^c   Van Der Helm van Mil, A H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d Section of Rheumatology   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; AUTOANTIBODY; CYCLOPEPTIDE;

ADULT; ARTICLE; BONE DESTRUCTION; BONE EROSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; BLOOD; IMMUNOLOGY;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FEMALE; HUMANS; MALE; PEPTIDES, CYCLIC; RHEUMATOID FACTOR;

EID: 84918497151     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-206623     Document Type: Article

References (6)

1. Hecht C, Englbrecht M, Rech J, et al. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA. Ann Rheum Dis 2014. Published Online First: 12 Aug 2014. doi:10.1136/annrheumdis-2014-205428
2. Harre U, Georgess D, Bang H, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 2012;122:1791-802.
3. de Rooy DPC, van der Linden MPM, Knevel R, et al. Predicting arthritis outcomes - what can be learned from the Leiden Early Arthritis Clinic? Rheumatology 2011;50:93-100.
4. Svensson B, Boonen A, Albertsson K, et al. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. Arthritis Rheum 2005;52:3360-70.
5. Knevel R, Tsonaka R, le Cessie S, et al. Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis. Scand J Rheumatol 2013;42:182-9.
6. de Rooy DPC, Andersson MLE, Knevel R, et al. Does the season at symptom onset influence the long-term severity of radiographic joint destruction in rheumatoid arthritis? Ann Rheum Dis 2012;71:2055-6.